Lanean...
Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant
Allogeneic hematopoietic cell transplantation (alloHCT) is a potentially curative treatment for myelodysplastic syndromes (MDS), but patients who relapse after transplant have poor outcomes. In order to understand the contribution of tumor clonal evolution to disease progression,we applied exome and...
Gorde:
| Argitaratua izan da: | JCI Insight |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
American Society for Clinical Investigation
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5922277/ https://ncbi.nlm.nih.gov/pubmed/29515031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.98962 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|